Related to Inovio Obtains $2.8M Grant to Advance Preclinical DNA Vaccines for HCV

• Medicago and IDRI Use DARPA Grant for Avian Flu Vaccine Development
  
• BARDA Doles Out $215M in Influenza Vaccine Contracts
  
• Kite Pharma Raises $15M in Initial Private Placement to Progress Anticancer Pipeline
  
• Medicago Achieves $3.8M Milestone under DARPA Contract to Build Vaccine Plant
  
• Allergy Therapeutics Firm Anergis Raises $20M in Series A Fundraising
  
• MabVax Wins $1.8M SBIR Grant to Support Phase II Sarcoma Vaccine Trial
  
• Aduro Licenses Cancer Immunotherapy from BioSante
  
• Oncothyreon Expects to Net $37.4M to Advance Cancer Pipeline
  
• Institute of Human Virology Awarded $23.4M to Fund Clinical Trials of HIV Vaccine
  
• Northwest Biotherapeutics Signs on Fraunhofer IZI for Brain Cancer Vaccine Development
  
• Nabi Stock Plummets as Smoking Cessation Immunotherapy Fails in First Phase III Trial
  
• BioSante Licenses Melanoma Vaccine to Hussman Foundation
  
• Sorrento Wins Second NIAID Grant of $600K to Develop Qourum Quenching Antibacterial
  
• $3M NIAID Grant Will Fund Inviragen Collaboration with UTMB to Develop Chikungunya Vaccine
  
• GeoVax Receives Latest Tranche of $19.6M NIAID Funding for HIV Vaccine
  
• Selecta Wins SAIC Subcontract to Develop Synthetic Nanoparticle Malaria Vaccine
  
• GeoVax Labs Receives $0.8M Funding Boost from NIAID to Progress HIV Vaccine
  
• Aduro BioTech Wins $250K in SBIR Grants and Contract with UNM for Vaccine Development
  
• MJFF Awards AFFiRiS $1.5M for Phase I Study with Peptide-Based Parkinson Disease Vaccine
  
• CureVac, Sanofi Pasteur, and In-Cell-Art Collaborate on €33.1M DARPA-Supported Vaccine Program